Boditech Med Income Statement

Health Care & Life Sciences » Medical Equipment & Supplies | Boditech Med Inc.

Boditech Med Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.

2013

2014

2015

2016

2017

Sales/Revenue

22,956

30,701

39,821

54,974

52,594

Cost of Goods Sold (COGS) incl. D&A

9,604

11,695

13,689

21,491

23,902

Gross Income

13,352

19,006

26,133

33,484

28,692

SG&A Expense

7,767

9,937

13,543

20,798

25,498

EBIT

5,490

8,925

12,375

12,386

2,874

Unusual Expense

519

13,877

125

3,766

Non Operating Income/Expense

129

597

235

1,290

1,100

Interest Expense

219

232

140

1,162

Pretax Income

5,869

9,681

893

13,844

2,957

Income Tax

465

1,093

1,533

182

Equity in Affiliates

Consolidated Net Income

5,379

8,587

1,986

12,311

3,139

Net Income

5,412

8,629

1,970

12,621

2,148

Net Income After Extraordinaries

5,412

8,629

1,970

12,621

2,148

Net Income Available to Common

5,412

8,629

1,970

12,621

2,148

EPS (Basic)

6,545.46

10,736.36

90.91

548.18

93.00

Basic Shares Outstanding

EPS (Diluted)

6,610.11

10,422.82

87.26

543.66

93.23

Diluted Shares Outstanding

EBITDA

6,386

10,174

13,952

14,828

6,502

Other Operating Expense

144

215

299

321

Non-Operating Interest Income

208

475

434

182

265

Minority Interest Expense

310

991

Equity in Affiliates (Pretax)

About Boditech Med

View Profile

Address	43 Geodudanji 1-gil Chuncheon GA 24398 Korea, Republic Of
Employees	-
Website	http://www.boditech.co.kr
Updated	09/14/2018
Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. Its products include iChroma II Reader, AFIAS6, iChroma Reader, Ichroma D, i-Chamber, and hemochroma PLUS. It also provides cardiac, tumor, diabetes, hormone, infection and rheumatoid arthritics tests.

Boditech Med Inc. | Income Statement

About Boditech Med

StatInvestor